Chemoinformaics analysis of (E,E)-Farnesa-1,6,9-trien-3,11-diol
Molecular Weight | 238.371 | nRot | 7 |
Heavy Atom Molecular Weight | 212.163 | nRig | 3 |
Exact Molecular Weight | 238.193 | nRing | 0 |
Solubility: LogS | -3.255 | nHRing | 0 |
Solubility: LogP | 2.417 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 43.9906 |
nHD | 2 | BPOL | 26.0834 |
QED | 0.668 |
Synth | 3.919 |
Natural Product Likeliness | 3.225 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.001 |
Pgp-sub | 0.001 |
HIA | 0.009 |
CACO-2 | -4.426 |
MDCK | 0.0000196 |
BBB | 0.547 |
PPB | 0.832963 |
VDSS | 0.913 |
FU | 0.14156 |
CYP1A2-inh | 0.022 |
CYP1A2-sub | 0.139 |
CYP2c19-inh | 0.168 |
CYP2c19-sub | 0.734 |
CYP2c9-inh | 0.055 |
CYP2c9-sub | 0.847 |
CYP2d6-inh | 0.132 |
CYP2d6-sub | 0.133 |
CYP3a4-inh | 0.606 |
CYP3a4-sub | 0.245 |
CL | 5.085 |
T12 | 0.775 |
hERG | 0.006 |
Ames | 0.002 |
ROA | 0.002 |
SkinSen | 0.842 |
Carcinogencity | 0.05 |
EI | 0.97 |
Respiratory | 0.005 |
NR-Aromatase | 0.012 |
Antiviral | Yes |
Prediction | 0.80227 |